ATE118012T1 - 2'-deoxy-2'-methylidenecytidin-dihydrat, verfahren zu ihrer herstellung und mischmaterial. - Google Patents

2'-deoxy-2'-methylidenecytidin-dihydrat, verfahren zu ihrer herstellung und mischmaterial.

Info

Publication number
ATE118012T1
ATE118012T1 AT91102225T AT91102225T ATE118012T1 AT E118012 T1 ATE118012 T1 AT E118012T1 AT 91102225 T AT91102225 T AT 91102225T AT 91102225 T AT91102225 T AT 91102225T AT E118012 T1 ATE118012 T1 AT E118012T1
Authority
AT
Austria
Prior art keywords
deoxy
production
mixing material
methylidenecytidine
dihydrate
Prior art date
Application number
AT91102225T
Other languages
English (en)
Inventor
Atsushi Sakai
Toshiyuki Shibata
Takayuki Ogawa
Shinji Sakata
Takanori Miyashita
Kazuhiko Kondo
Original Assignee
Yoshitomi Pharmaceutical
Yamasa Shoyu Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshitomi Pharmaceutical, Yamasa Shoyu Kk filed Critical Yoshitomi Pharmaceutical
Application granted granted Critical
Publication of ATE118012T1 publication Critical patent/ATE118012T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
AT91102225T 1990-02-19 1991-02-16 2'-deoxy-2'-methylidenecytidin-dihydrat, verfahren zu ihrer herstellung und mischmaterial. ATE118012T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2037695A JPH0615557B2 (ja) 1990-02-19 1990-02-19 ２’―デオキシ―２’―メチリデンシチジンの２水和物結晶

Publications (1)

Publication Number Publication Date
ATE118012T1 true ATE118012T1 (de) 1995-02-15

Family

ID=12504690

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91102225T ATE118012T1 (de) 1990-02-19 1991-02-16 2'-deoxy-2'-methylidenecytidin-dihydrat, verfahren zu ihrer herstellung und mischmaterial.

Country Status (9)

Country Link
US (2) US5183882A (de)
EP (1) EP0443471B1 (de)
JP (1) JPH0615557B2 (de)
KR (2) KR960010947B1 (de)
AT (1) ATE118012T1 (de)
CA (1) CA2036507C (de)
DE (1) DE69107098T2 (de)
DK (1) DK0443471T3 (de)
ES (1) ES2067780T3 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5401726A (en) * 1988-08-25 1995-03-28 Yoshitomi Pharaceutical Industries, Ltd. 2'methylidenepyrimidine nucleoside compounds, their use and method for production thereof
JPH0615557B2 (ja) * 1990-02-19 1994-03-02 ヤマサ醤油株式会社 ２’―デオキシ―２’―メチリデンシチジンの２水和物結晶
US5589587A (en) * 1992-05-12 1996-12-31 Merrell Pharmaceuticals Inc. Process for the preparation of ribonucleotide reductase inhibitors
NZ273129A (en) * 1993-08-19 1996-08-27 Merck & Co Inc 4"-deoxy-4"-epi-methylamino avermectin b1a/b1b benzoic acid salt hemihydrate; pesticidal compositions
DE69421721T2 (de) * 1994-01-07 2000-04-27 Merrell Pharma Inc (e)-2'-deoxy-2'-(fluormethylen)cytidin-monohydrat
EP0770621A4 (de) * 1994-07-12 1998-01-28 Yamasa Corp 2'-deoxy-2'(substituiertes oder unsubstituiertes methylidene)-4-thionukleosid
US5665711A (en) * 1995-12-12 1997-09-09 Yoshitomi Pharmaceutical Industries, Ltd. Antitumor composition for oral administration
EP2106788A1 (de) * 2008-04-04 2009-10-07 Ipsen Pharma Flüssige und lyophilisierte Formulierungen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910008800B1 (ko) * 1987-03-19 1991-10-21 야마사 쇼오유 가부시끼가이샤 2'-알킬리덴 피리미딘 누클레오시드 유도체, 그 제조법, 및 그 용도
JPS63258818A (ja) * 1987-04-16 1988-10-26 Yoshitomi Pharmaceut Ind Ltd 制ガン剤
DE68922899T2 (de) * 1988-12-07 1995-10-12 Yoshitomi Pharmaceutical Verbindungen von Pyrimidin 2'-Methylidin Nukleosiden.
JPH0615557B2 (ja) * 1990-02-19 1994-03-02 ヤマサ醤油株式会社 ２’―デオキシ―２’―メチリデンシチジンの２水和物結晶

Also Published As

Publication number Publication date
ES2067780T3 (es) 1995-04-01
JPH0615557B2 (ja) 1994-03-02
DK0443471T3 (da) 1995-06-26
DE69107098D1 (de) 1995-03-16
CA2036507A1 (en) 1991-08-20
KR970005016A (ko) 1997-01-29
KR910021351A (ko) 1991-12-20
EP0443471A1 (de) 1991-08-28
US5183882A (en) 1993-02-02
EP0443471B1 (de) 1995-02-01
KR0174212B1 (ko) 1999-02-01
US5412089A (en) 1995-05-02
JPH03240794A (ja) 1991-10-28
KR960010947B1 (ko) 1996-08-14
DE69107098T2 (de) 1995-06-29
CA2036507C (en) 1996-09-10

Similar Documents

Publication Publication Date Title
FI93831B (fi) Tetratsolit, jotka ovat verenpainetta alentavien yhdisteiden välituotteita
HU206683B (en) Process for producing 1,5-diphenyl-pyrazolo-3-carboxylic acid derivatives and selective herbicide compositions containing them as antidotum
DE3784401D1 (de) Karbostyril-derivate und ihre salze, verfahren zu ihrer herstellung und diese enthaltende kardiotonische zusammensetzung.
DE3776261D1 (de) Naehrstoffzusammensetzung.
DE3771376D1 (de) Indol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3850366D1 (de) Ternäre Foto-Initiatorzusammensetzung zur Additionspolymerisation.
ATE118012T1 (de) 2'-deoxy-2'-methylidenecytidin-dihydrat, verfahren zu ihrer herstellung und mischmaterial.
DE3872620D1 (de) (arylsulphonyl)-nitromethane, verfahren zu deren herstellung und deren verwendung in pharmazeutischen zusammensetzungen.
FI881609A0 (fi) Dihydropyridinamider, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
DE69012619T2 (de) Bis(1-Hydrocarbyloxy-2,2,6,6-tetramethylpiperidin-4-yl)-amin-derivate und stabilisierte Zusammensetzungen.
DE3750029D1 (de) Cinnolin-Derivate, Verfahren zu deren Herstellung und diese enthaltende herbizide Zusammenstellung.
DE3586817T2 (de) 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
PT87563A (pt) Process for the preparation of vinylcephalosporins useful as medicaments
DE3483628D1 (de) 1,n-diaryl-4,5-dihydro-1h-pyrazol-3-amine, diese enthaltende zusammensetzungen und verfahren zu ihrer herstellung.
ATE85185T1 (de) 1,4-naphthochinonderivate enthaltende rodentizide zusammensetzungen.
DE3773240D1 (de) Hydrochinolinverbindungen, diese enthaltende zusammensetzungen und verfahren zu ihrer herstellung.
DE59107545D1 (de) Salicylaldehyd- und Salicylsäurederivate sowie deren Schwefelanaloge, Verfahren und Zwischenprodukte zu ihrer Herstellung
FI905350A0 (fi) Komposition innehaollande maerkta streptokock-antikroppar,testfoerpackning och analysfoerfarande, i vilket den anvaends.
DE3789032D1 (de) Mechanismus zur Einstellung eines Ausgangsgliedes.
PT86665A (pt) Process for the preparation of 14,15-substituted lanosterols and of hypocholesterolemic compositions containing the same
ATE133177T1 (de) 3'-deamino-4'-deoxy-4'-amino-8-fluoranthracycli e und verfahren zu ihrer herstellung
DE3887626D1 (de) 2-Oxa-isocephem-Verbindungen, diese enthaltende Zusammensetzungen und Verfahren zu deren Herstellung.
DE3888697T2 (de) 2,3-thiomorpholinedion-2-oxim-derivate, arzneimittelzusammensetzungen und verfahren zur herstellung.
PT81427B (de) 3,4-diazolderivate verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FI874653A0 (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara n-acylerade derivat av bis (2-imidazolin-2-ylhydrazoner) av 9,10-antracendikarboxialdehyd.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee